A critical advance in cancer study is arising with the use of VHH fragments to re-engage mutated p53. This essential tumor inhibitor protein is frequently lost in several kinds of tumors, resulting uncontrolled body https://www.zenhealths.com/p53-reactivation-nanobody-cancer-research